To this end, we will compare the characteristics of our ERP with ERP in studies having used pharmacological challenges (i.e., dopaminergic agonists) and demonstrate morphological similarities in both the MMN component and the Nd component.
Sub-diagnostic levels of such symptoms are not associated with reduced treatment response to ERP, in fact ERP is associated with a reduction in both psychotic- and schizotypal symptoms.
We assessed the latency of ERP negative peak, adjacent to the area that the ERP in response to PR trials dissociated from ERP in response to WR trials (i.e. N150 and N200 in frontal and parietal cortices, respectively).
While both treatment conditions showed significant symptom reduction, therapist-administered ERP was superior to self-administered ERP in improving OCD symptoms and self-reported functional impairment [ 681].
According to the Aberdeen Group's "ERP in SME: Fueling Growth and Profit" (PDF), an ERP deployment brings around 22percentt reduction in operating costs, 20percentt in administrative costs, 17percentt reduction in inventory management cost, and around the same level of improvements in both scheduled compliance and on-time delivery.
However, it should be taken into account that a strict separation of cognitive interventions in ERP treatment is difficult because cognitive techniques are associated with ERP in some way in most studies [ 2].
To assess potential differences in ERP amplitude on the group level, we performed a cluster-based permutation dependent samples t-test61, comparing the ERP in trials where the first versus the second tone was later chosen as higher in pitch.
Using the modified paradigm we thus recorded ERP in addition to lexical decision times.
We compared auditory P300 ERP in patients remitted from ATPD with schizophrenia in remission and biologically unrelated healthy controls.
